Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting

Author:

Miyahira Andrea K.1ORCID,Cheng Heather H.23,Abida Wassim4,Ellis Leigh56,Harshman Lauren C.7ORCID,Spratt Daniel E.8,Simons Jonathan W.1,Pienta Kenneth J.91011,Soule Howard R.1

Affiliation:

1. Prostate Cancer Foundation; Santa Monica California

2. Department of Medicine; University of Washington; Seattle Washington

3. Division of Clinical Research; Fred Hutchinson Cancer Research Center; Seattle Washington

4. Genitourinary Oncology Service, Department of Medicine; Memorial Sloan Kettering Cancer Center; New York New York

5. Department of Oncologic Pathology; Dana-Farber Cancer Institute; Boston Massachusetts

6. Department of Pathology; Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts

7. Lank Center for Genitourinary Oncology; Dana-Farber Cancer Institute and Harvard Medical School; Boston Massachusetts

8. Department of Radiation Oncology; University of Michigan; Ann Arbor Michigan

9. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center; The Johns Hopkins School of Medicine; Baltimore Maryland

10. Department of Urology; The James Buchanan Brady Urological Institute; Baltimore Maryland

11. Department of Pharmacology and Molecular Sciences; The Johns Hopkins School of Medicine; Baltimore Maryland

Publisher

Wiley

Subject

Urology,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3